Novo Nordisk sues Eli Lilly, accusing it of false advertising

Novo Nordisk has filed a lawsuit against Eli Lilly, accusing the company of misleading consumers by using outdated clinical trial data to make its drugs appear more effective than Novo's. The dispute centers on allegations of false advertising related to drug efficacy comparisons.